BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Pharmaceutical Profiles to share unique expertise

Pharmaceutical Profiles is to host a number of seminars in the US, sharing their unique expertise of effective clinical evaluation of oral drug delivery. In addition to hearing about the most recent case studies and technologies, delegates can have their questions answered by industry experts. Speakers will include Lloyd Stevens PhD, Principal Scientist, and Peter Scholes PhD, Head of Pharmaceutical Science – both from Pharmaceutical Profiles.

The company’s education programme will continue in November with a free webinar: “Evaluation of human regional bioavailability to assess whether modified release development is feasible.” Visit www.pharmprofiles.com to register.

With pressure to develop ‘once a day drugs’, it is important to establish early in any drug development program whether modified release formulation is feasible for the drug and to identify the most efficient formulation strategy to achieve an extended release profile. Pharmaceutical Profiles combines unique technology and know-how to visualise and quantify formulation performance in the clinic.



Text ends

Seminar dates
15 October 2007 – Lunchtime seminar - Waltham, MA

“Effective clinical evaluation of oral drug delivery”
Speaker: Lloyd Stevens PhD, Principal Scientist, Pharmaceutical Profiles

16 October 2007 – Lunchtime seminar – Cambridge, MA

“Taking the guesswork out of modified release formulation development”
Speaker: Lloyd Stevens PhD, Principal Scientist, Pharmaceutical Profiles

01 November 2007 – Breakfast seminar – Durham, NC

“Effective clinical evaluation of oral drug delivery”
Speaker: Peter Scholes PhD, Head of Pharmaceutical Sciences

02 November 2007 – Breakfast seminar – Whippany, NJ

“Effective clinical evaluation of oral drug delivery”
Speaker: Peter Scholes PhD, Head of Pharmaceutical Sciences

06 November 2007 – Webinar

“Evaluation of human regional bioavailability to assess whether modified
release development is feasible”
 
www.pharmprofiles.com

For further information:

Press information
Richard Kent, Kapler Communications
Tel: +44 (0)1480 479 280 Fax: +44 (0) 1480 470 343
richard@kapleronline.com

Company contact:
Karen Jones PhD, Vice President, Marketing, Pharmaceutical Profiles Ltd
Tel: +44 (0)115 974 9000
karen.jones@pharmprofiles.co.uk
 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.